ribavirin has been researched along with mk 0608 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gahan, ME; Keller, PA; Mahalingam, S; Stevens, AJ | 1 |
| Botta, M; Brai, A; Falsitta, L; Fazi, R; Garbelli, A; Giannecchini, S; Maccari, L; Maga, G; Martelli, F; Pollutri, A; Riva, V; Ronzini, S; Zamperini, C | 1 |
| Costantino, G; Kaptein, SJF; Neyts, J; Radi, M; Vincetti, P | 1 |
| Flamand, M; Liu, W; Schul, W; Vasudevan, SG; Xu, HY | 1 |
1 review(s) available for ribavirin and mk 0608
| Article | Year |
|---|---|
The medicinal chemistry of dengue fever.
Topics: Antiviral Agents; Dengue; Dengue Virus; Humans; Models, Molecular; Viral Proteins | 2009 |
3 other study(ies) available for ribavirin and mk 0608
| Article | Year |
|---|---|
DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection.
Topics: A549 Cells; Animals; Antiviral Agents; Chlorocebus aethiops; DEAD-box RNA Helicases; Enzyme Inhibitors; Humans; Vero Cells; Virus Replication; West Nile Fever; West Nile virus | 2019 |
Scaffold Morphing Approach To Expand the Toolbox of Broad-Spectrum Antivirals Blocking Dengue/Zika Replication.
Topics: | 2019 |
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.
Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Dengue; Disease Models, Animal; Dose-Response Relationship, Drug; Indolizines; Mice; Ribavirin; Time Factors; Tubercidin; Viremia; Virus Replication | 2007 |